Vaginal discharge

British Medical Journal

Volumn 335, Issue 7630, 2007, Pages 1147-1151

  Spence, Des ^a   Melville, Catriona ^b  

^a Maryhill Health and Care Centre and University of Glasgow   (United Kingdom)

^b Sandyford Initiative   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CLINDAMYCIN; CLOTRIMAZOLE; DOXYCYCLINE; ECONAZOLE; FLUCONAZOLE; METRONIDAZOLE; MICONAZOLE;

CANDIDIASIS; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DOSE RESPONSE; DRUG EFFICACY; GONORRHEA; HUMAN; MEDICAL EXAMINATION; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; URINALYSIS; VAGINA DISCHARGE; VAGINITIS; VIRUS TRANSMISSION; WOMEN'S HEALTH;

ANTI-INFECTIVE AGENTS; CONTACT TRACING; FEMALE; HUMANS; HYGIENE; MEDICAL HISTORY TAKING; PATIENT EDUCATION AS TOPIC; PHYSICAL EXAMINATION; REFERRAL AND CONSULTATION; SEXUALLY TRANSMITTED DISEASES; VAGINAL DISCHARGE; VAGINAL SMEARS; VAGINOSIS, BACTERIAL;

EID: 37049021521     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39378.633287.80     Document Type: Review

References (29)

1. Glasier A, Metin Gulmezoglu A, Schmitt GP, Garcia Moreno C, Van Look PFA. Sexual and reproductive health: a matter of life and death. Lancet 2006;368:1595-607.
2. O'Dowd TC, Parker S, Kelly A. Women's experiences of general practitioners' management of their vaginal symptoms. Br J Gen Pract 1996;46:415-8.
3. Shaw C, Mason M, Scoular A. Group B streptococcus carriage and vulvovaginal symptoms: causal or casual? A case-control study in a GUM clinic population. Sex Transm Infect 2003;79:246-8.
4. Hay P. National guideline for the management of bacterial vaginosis. Clinical Effectiveness Group. British Association for Sexual Health and HIV. 2006. www.bashh.org/guidelines/2006/bv_final_0706.pdf.
5. FPRHC and BASHH Guidance. The management of women of reproductive age attending non-genitourinary medicine settings complaining of vaginal discharge. J Farn Plann Reprod Health Care 2006;32:33-42.
6. Wilson J. Vaginal discharge. In: Walker J, ed. Sexual health in obstetrics and gynaecology. 1st ed. London: Remedica, 2003:33-51.
7. Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Infect 2004;80:8-11.
8. Daniels D. Forster national guideline on the management of vulvovaginal candidiasis. G. Clinical Effectiveness group (British Association for Sexual Health and HIV). 2002.
9. Spence D. Candidiasis (vulvovaginal). Clin Evid 2006;15:2403-18.
10. WHO. Sexually transmitted and other reproductive tract infections. 1 Sexually transmitted diseases. 2 HIV infections. 3 Genital diseases, female. 4 Genital diseases, male. 5 Infection. 6 Pregnancy complications, infectious. 7 Rape. 8 Practice guidelines. 9 Developing countries. Geneva: WHO, 2005.
11. Brown AE, Sadler KE, Tomkins SE, McGarrigle CA, LaMontagne DS, Goldberg D, et al. Recent trends in HIV and other STIs in the United Kingdom: data to the end of 2002. Sex Transm Infect 2004;80:159-66.
12. Burckhardt F, Warner P, Young H. What is the impact of change in diagnostic test method on suiveillance data trends in Chlamydia trachomatis infection? Sex Transm Infect 2006;82:24-30.
13. Horner PJ, Boag F. National guideline for the management of genital tract infection with Chlamydia trachomatis. Clinical Effectiveness group. British Association for Sexual Health and HIV. 2006. www.bashh.org/guidelines/ 2006/chlamydia_0706.pdf.
14. Low N, Egger M, Sterne JA, Harbord R, Ibrahim F, Lindblom B, et al. Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala women's cohort study. Sex Transm Infect 2006;82:212-8.
15. Morré SA, van den Brule AJC, Rozendaal L, Boeke AJ, Voorhorst FJ, de Blok S, et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow up. Int J STD AIDS 2002;13(suppl 2):12-8.
16. Bignell C. National guideline on the diagnosis and treatment of gonorrhoea in adults. Clinical Effectiveness group. British Association for Sexual Health and HIV. 2005. www.bashh.org/guidelines/2005/gc_final_0805.pdf.
17. Sherrard J. National guideline on the management of Trichomonas vaginalis. Clinical Effectiveness group. British Association for Sexual Health and HIV. 2007. www.bashh.org/guidelines/2007/tv0607.pdf.
18. Van Bergen JE, Spaargaren J, Gotz HM, Veldhuijzen IK, Bindels PJ, Coenen TJ, et al. Should asymptomatic persons be tested during population-based Chlamydia screening also for gonorrhoea or only if chlamydial infection is found? BMC Infect Dis 2006;6:42.
19. Blake DR, Fletcher K, Joshi NI, Emans SJ. Identification of symptoms that indicate a pelvic examination is necessary to exclude PID in adolescent women. J Pediatr Adolesc Gynecol 2003;16:25-30.
20. Padilla LA, Radosevich DM, Milad MP. Limitations of the pelvic examination for evaluation of the female pelvic organs. Int J Gynaecol Obstet 2005;88:84-8.
21. Melville C, Nandwani R, Bigrigg A, McMahon AD. A comparative study of clinical management strategies for vaginal discharge in family planning and genitourinary medicine settings. J Fam Plann Reprod Health Care 2005;31:26-30.
22. Thinkhamrop J, Lumbiganon P, Thongkrajai P, Chongsomchai C, Pakarasang M. Vaginal fluid pH as a screening test for vaginitis. Int J Gynaecol Obstet 1999;66:143-8.
23. Cook RL, Hutchison S, Ostergaard L, Braithwaite S, Ness RB. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005;142:914-25.
24. Garrow SC, Smith DW, Harnett GB. The diagnosis of Chlamydia, gonorrhoea, and trichomonas infections by self obtained low vaginal swabs, in remote northern Australian clinical practice Sex Transm Infect 2002;78:278-81.
25. Gaydos CA, Crotchfelt KA, Shah N, Tennant M, Quinn TC, Gaydos JC, et al. Evaluation of dry and wet transported intravaginal swabs in detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in female soldiers by PCR. J Clin Microbiol 2002;40:758-61.
26. Chernesky MA, Hook EW 3rd, Martin DH, Lane J, Johnson R, Jordan JA, et al. Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections. Sex Transm Dis 2005;32:729-33.
27. Wilson JD, Shann SM, Brady SK, Mammen-Tobin AG, Evans AL, Lee RA. Recurrent bacterial vaginosis: the use of maintenance acidic vaginal gel following treatment. Int J STD AIDS 2005;16:736-8.
28. Trelle S, Shang A, Nartey L, Cassell JA, Low N. Improved effectiveness of partner notification for patients with sexually transmitted infections: systematic review. BMJ 2007;334:354.
29. Low N, McCarthy A, Roberts TE, Huengsberg M, Sanford E, Sterne JAC, et al. Partner notification of chlamydia infection in primary care: randomised controlled trial and analysis of resource use. BMJ 2006;332:14-9.